528 related articles for article (PubMed ID: 11493009)
21. A model of Cdc25 phosphatase catalytic domain and Cdk-interaction surface based on the presence of a rhodanese homology domain.
Hofmann K; Bucher P; Kajava AV
J Mol Biol; 1998 Sep; 282(1):195-208. PubMed ID: 9733650
[TBL] [Abstract][Full Text] [Related]
22. Conservation of structure and function among histidine-containing phosphotransfer (HPt) domains as revealed by the crystal structure of YPD1.
Xu Q; West AH
J Mol Biol; 1999 Oct; 292(5):1039-50. PubMed ID: 10512701
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation.
Stewart AE; Dowd S; Keyse SM; McDonald NQ
Nat Struct Biol; 1999 Feb; 6(2):174-81. PubMed ID: 10048930
[TBL] [Abstract][Full Text] [Related]
24. ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1.
Tárrega C; Ríos P; Cejudo-Marín R; Blanco-Aparicio C; van den Berk L; Schepens J; Hendriks W; Tabernero L; Pulido R
J Biol Chem; 2005 Nov; 280(45):37885-94. PubMed ID: 16148006
[TBL] [Abstract][Full Text] [Related]
25. The crystal structure of the olfactory marker protein at 2.3 A resolution.
Smith PC; Firestein S; Hunt JF
J Mol Biol; 2002 Jun; 319(3):807-21. PubMed ID: 12054872
[TBL] [Abstract][Full Text] [Related]
26. Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases.
Eswaran J; von Kries JP; Marsden B; Longman E; Debreczeni JE; Ugochukwu E; Turnbull A; Lee WH; Knapp S; Barr AJ
Biochem J; 2006 May; 395(3):483-91. PubMed ID: 16441242
[TBL] [Abstract][Full Text] [Related]
27. Evolution of the multifunctional protein tyrosine phosphatase family.
Pils B; Schultz J
Mol Biol Evol; 2004 Apr; 21(4):625-31. PubMed ID: 14739250
[TBL] [Abstract][Full Text] [Related]
28. Functional assignment of MAPK phosphatase domains.
Nordle AK; Rios P; Gaulton A; Pulido R; Attwood TK; Tabernero L
Proteins; 2007 Oct; 69(1):19-31. PubMed ID: 17596826
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of Streptomyces olivaceoviridis E-86 beta-xylanase containing xylan-binding domain.
Fujimoto Z; Kuno A; Kaneko S; Yoshida S; Kobayashi H; Kusakabe I; Mizuno H
J Mol Biol; 2000 Jul; 300(3):575-85. PubMed ID: 10884353
[TBL] [Abstract][Full Text] [Related]
30. Structure of human DSP18, a member of the dual-specificity protein tyrosine phosphatase family.
Jeong DG; Cho YH; Yoon TS; Kim JH; Son JH; Ryu SE; Kim SJ
Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):582-8. PubMed ID: 16699184
[TBL] [Abstract][Full Text] [Related]
31. Structure of GSK3beta reveals a primed phosphorylation mechanism.
ter Haar E; Coll JT; Austen DA; Hsiao HM; Swenson L; Jain J
Nat Struct Biol; 2001 Jul; 8(7):593-6. PubMed ID: 11427888
[TBL] [Abstract][Full Text] [Related]
32. Electrostatic evaluation of the signature motif (H/V)CX5R(S/T) in protein-tyrosine phosphatases.
Peters GH; Frimurer TM; Olsen OH
Biochemistry; 1998 Apr; 37(16):5383-93. PubMed ID: 9548920
[TBL] [Abstract][Full Text] [Related]
33. Residue 259 in protein-tyrosine phosphatase PTP1B and PTPalpha determines the flexibility of glutamine 262.
Peters GH; Iversen LF; Andersen HS; Møller NP; Olsen OH
Biochemistry; 2004 Jul; 43(26):8418-28. PubMed ID: 15222753
[TBL] [Abstract][Full Text] [Related]
34. The structure of the membrane distal phosphatase domain of RPTPalpha reveals interdomain flexibility and an SH2 domain interaction region.
Sonnenburg ED; Bilwes A; Hunter T; Noel JP
Biochemistry; 2003 Jul; 42(26):7904-14. PubMed ID: 12834342
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
36. Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteine-containing target peptides.
van den Berk LC; Landi E; Harmsen E; Dente L; Hendriks WJ
FEBS J; 2005 Jul; 272(13):3306-16. PubMed ID: 15978037
[TBL] [Abstract][Full Text] [Related]
37. Multimerisation of receptor-type protein tyrosine phosphatases PTPBR7 and PTP-SL attenuates enzymatic activity.
Noordman YE; Augustus ED; Schepens JT; Chirivi RG; Ríos P; Pulido R; Hendriks WJ
Biochim Biophys Acta; 2008 Feb; 1783(2):275-86. PubMed ID: 18068678
[TBL] [Abstract][Full Text] [Related]
38. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.
Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ
Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of the low-molecular-mass phosphotyrosine-protein phosphatase of Acinetobacter johnsonii.
Grangeasse C; Doublet P; Vincent C; Vaganay E; Riberty M; Duclos B; Cozzone AJ
J Mol Biol; 1998 May; 278(2):339-47. PubMed ID: 9571056
[TBL] [Abstract][Full Text] [Related]
40. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
